zepbound and compound tirzepatide Compounded Injections $100 Zepbound No Longer in Shortage:

However, the company is still very new, and it shows

[5] Unlicensed medicines can, in limited circumstances, be supplied on a named-patient 'specials' basis under MHRA and GMC guidance but this applies only where there is a documented clinical need that cannot be met by a licensed product, and it does not extend to cosmetic, body composition, or weight-loss indications

If further improvement in glycemic control or weight management is required, the dose is recommended to be increased in 2.5 mg increments after at least four weeks of treatment at the current dose

Evidence-based treatments reduce relapse risks and improve long-term recovery outcomes